Abstract
The functioning of opioid receptors involves a wide range of processes. Their association with G-proteins is clearly one of the most important. However, receptor trafficking also plays a crucial role in their activation, inactivation and desensitization. This review will attempt to summarize the receptors from their synthesis to their eventual proteolytic elimination.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Chavan M, Lennarz W (2006) The molecular basis of coupling of translocation and N-glycosylation. Trends Biochem Sci 31(1):17–20
Ruddock LW, Molinari M (2006) N-glycan processing in ER quality control. J Cell Sci 119(Pt 21):4373–4380
Helenius A, Aebi M (2001) Intracellular functions of N-linked glycans. Science 291(5512):2364–2369
Petaja-Repo UE et al (2000) Newly synthesized human delta opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome. J Biol Chem 276:4416–4423
Margeta-Mitrovic M, Jan YN, Jan LY (2000) A trafficking checkpoint controls GABA(B) receptor heterodimerization. Neuron 27(1):97–106
Simonds WF et al (1985) Purification of the opiate receptor of NG108-15 neuroblastoma-glioma hybrid cells. Proc Natl Acad Sci USA 82(15):4974–4978
Jordan BA, Devi LA (1999) G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399(6737):697–700
Hasbi A et al (2007) Trafficking of preassembled opioid mu-delta heterooligomer-Gz signaling complexes to the plasma membrane: coregulation by agonists. Biochemistry 46(45):12997–13009
Loo TW, Clarke DM (2007) Chemical and pharmacological chaperones as new therapeutic agents. Expert Rev Mol Med 9(16):1–18
Petaja-Repo UE et al (2002) Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation. Embo J 21(7):1628–1637
Farquhar MG, Palade GE (1998) The Golgi apparatus: 100 years of progress and controversy. Trends Cell Biol 8(1):2–10
Wang H, Pickel VM (2001) Preferential cytoplasmic localization of delta-opioid receptors in rat striatal patches: comparison with plasmalemmal mu-opioid receptors. J Neurosci 21(9):3242–3250
Cheng PY, Liu-Chen LY, Pickel VM (1997) Dual ultrastructural immunocytochemical labeling of mu and delta opioid receptors in the superficial layers of the rat cervical spinal cord. Brain Res 778(2):367–380
Cahill CM et al (2001) Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception. J Neurosci 21(19):7598–7607
Kim KA, von Zastrow M (2003) Neurotrophin-regulated sorting of opioid receptors in the biosynthetic pathway of neurosecretory cells. J Neurosci 23(6):2075–2085
Guan JS et al (2005) Interaction with vesicle luminal protachykinin regulates surface expression of delta-opioid receptors and opioid analgesia. Cell 122(4):619–631
Lefkowitz RJ et al (1998) Mechanisms of beta-adrenergic receptor desensitization and resensitization. Adv Pharmacol 42(2):416–420
Kovoor A et al (1998) Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy. Mol Pharmacol 54(4):704–711
Terman GW et al (2004) G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal. Br J Pharmacol 141(1):55–64
Bohn LM et al (1999) Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286(5449):2495–2498
Zhang J et al (1998) Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc Natl Acad Sci USA 95(12):7157–7162
Whistler JL, von Zastrow M (1998) Morphine-activated opioid receptors elude desensitization by beta-arrestin. Proc Natl Acad Sci USA 95:9914–9919
Gainetdinov RR et al (2004) Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci 27:107–144
Law P-Y, Hom DS, Loh HH (1982) Loss of opiate receptor activity in neuroblastoma × glioma NG108-15 cells after chronic etorphine treatment: a multiple step process. Mol Pharmacol 72:1–4
von Zastrow M, Keith DEJ, Evans CJ (1993) Agonist-induced state of the delta-opioid receptor that discriminates between opioid peptides and opiate alkaloids. Mol Pharmacol 44(1):166–172
Keith DE et al (1996) Morphine activates opioid receptors without causing their rapid internalization. J Biol Chem 271(32):19021–19024
Chu P et al (1997) Delta and kappa opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist. J Biol Chem 272(43):27124–27130
Tsao PI, von Zastrow M (2001) Diversity and specificity in the regulated endocytic membrane trafficking of G-protein-coupled receptors. Pharmacol Ther 89(2):139–147
Gruenberg J, Maxfield FR (1995) Membrane transport in the endocytic pathway. Curr Opin Cell Biol 7(4):552–563
Goodman OJ et al (1996) Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature 383(6599):447–450
Ferguson SS et al (1996) Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science 271(5247):363–366
Goodman OB Jr et al (1998) Role of arrestins in G-protein-coupled receptor endocytosis. Adv Pharmacol 42(4):429–433
Carman CV, Benovic JL (1998) G-protein-coupled receptors: turn-ons and turn-offs. Curr Opin Neurobiol 8(3):335–344
Ferguson SS et al (1998) Molecular mechanisms of G protein-coupled receptor desensitization and resensitization. Life Sci 62(17–18):1561–1565
Zhang J et al (1999) Agonist-specific regulation of delta-opioid receptor trafficking by G protein-coupled receptor kinase and beta-arrestin. J Receptor Signal Transduct Res 19(1–4):301–313
Pasternak GW (2004) Multiple opiate receptors: deja vu all over again. Neuropharmacology 47(Suppl 1):312–323
Koch T et al (2001) C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization. J Biol Chem 276(33):31408–31414
Cvejic S, Devi LA (1997) Dimerization of the delta opioid receptor: implication for a role in receptor internalization. J Biol Chem 272(43):26959–26964
Rios CD et al (2001) G-protein-coupled receptor dimerization: modulation of receptor function. Pharmacol Ther 92(2–3):71–87
He L et al (2002) Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 108(2):271–282
Keith DE et al (1998) mu-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol Pharmacol 53(3):377–384
Alvarez VA et al (2002) mu-opioid receptors: ligand-dependent activation of potassium conductance, desensitization, and internalization. J Neurosci 22(13):5769–5776
Yu Y et al (1997) Mu opioid receptor phosphorylation, desensitization, and ligand efficacy. J Biol Chem 272(46):28869–28874
Whistler JL et al (1999) Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 23(4):737–746
Celver J et al (2004) Distinct domains of the mu-opioid receptor control uncoupling and internalization. Mol Pharmacol 65(3):528–537
Groer CE et al (2007) An opioid agonist that does not induce micro-opioid receptor–arrestin interactions or receptor internalization. Mol Pharmacol 71(2):549–557
Urban JD et al (2007) Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther 320:1–13
Kobilka BK, Deupi X (2007) Conformational complexity of G-protein-coupled receptors. Trends Pharmacol Sci 28(8):397–406
Kenakin T (2007) Functional selectivity through protean and biased agonism: who steers the ship? Mol Pharmacol 72(6):1393–1401
Swaminath G et al (2004) Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states. J Biol Chem 279(1):686–691
Tsao PI, von Zastrow M (2000) Type-specific sorting of G protein-coupled receptors after endocytosis. J Biol Chem 275(15):11130–11140
Saksena S et al (2007) ESCRTing proteins in the endocytic pathway. Trends Biochem Sci 32(12):561–573
Bache KG et al (2003) STAM and Hrs are subunits of a multivalent ubiquitin-binding complex on early endosomes. J Biol Chem 278(14):12513–12521
Hislop JN, Marley A, Von Zastrow M (2004) Role of mammalian VPS proteins in endocytic trafficking of a non-ubiquitinated G protein-coupled receptor to lysosomes. J Biol Chem 279:22522–22531
Babst M et al (1998) The Vps4p AAA ATPase regulates membrane association of a Vps protein complex required for normal endosome function. Embo J 17(11):2982–2993
Tanowitz M, von Zastrow M (2002) Ubiquitination-independent trafficking of G protein-coupled receptors to lysosomes. J Biol Chem 277(52):50219–50222
Whistler JL et al (2002) Modulation of post-endocytic sorting of G protein-coupled receptors. Science 297:615–620
Simonin F et al (2004) Identification of a novel family of G protein-coupled receptor associated sorting proteins. J Neurochem 89(3):766–775
Tanowitz M, von Zastrow M (2003) A novel endocytic recycling signal that distinguishes the membrane trafficking of naturally occurring opioid receptors. J Biol Chem 278(46):45978–45986
Hanyaloglu AC, von Zastrow M (2008) Regulation of GPCRs by membrane trafficking and its potential implications. Annu Rev Pharmacol Toxicol 48:537–568
Pak Y et al (1996) Agonist-induced functional desensitization of the mu-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein. Mol Pharmacol 50(5):1214–1222
Koch T et al (1998) Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization. J Biol Chem 273(22):13652–13657
Law PY, Wong YH, Loh HH (2000) Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 40:389–430
Qiu Y, Law PY, Loh HH (2003) Mu-opioid receptor desensitization: role of receptor phosphorylation, internalization, and representation. J Biol Chem 278(38):36733–36739
Arttamangkul S et al (2006) Separation of mu-opioid receptor desensitization and internalization: endogenous receptors in primary neuronal cultures. J Neurosci 26(15):4118–4125
Kelly E, Bailey CP, Henderson G (2008) Agonist-selective mechanisms of GPCR desensitization. Br J Pharmacol 153:S379–S388
Pippig S, Andexinger S, Lohse MJ (1995) Sequestration and recycling of beta 2-adrenergic receptors permit receptor resensitization. Mol Pharmacol 47(4):666–676
Yu SS, Lefkowitz RJ, Hausdorff WP (1993) Beta-adrenergic receptor sequestration. A potential mechanism of receptor resensitization. J Biol Chem 268(1):337–341
Koch T, Hollt V (2008) Role of receptor internalization in opioid tolerance and dependence. Pharmacol Ther 117:199–206
Schulz S et al (2004) Morphine induces terminal micro-opioid receptor desensitization by sustained phosphorylation of serine-375. Embo J 23(16):3282–3289
Law P-Y, Hom DS, Loh HH (1984) Down-regulation of opiate receptor in neuroblastoma x glioma NG108-15 hybrid cells: chloroquine promotes accumulation of tritiated enkephalin in the lysosomes. J Biol Chem 259:4096–4104
Tsao P, Cao T, von Zastrow M (2001) Role of endocytosis in mediating downregulation of G-protein-coupled receptors. Trends Pharmacol Sci 22(2):91–96
Martini L, Whistler JL (2007) The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence. Curr Opin Neurobiol 17(5):556–564
Scherrer G et al (2006) Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo. Proc Natl Acad Sci USA 103(25):9691–9696
Coolen LM et al (2004) Activation of mu opioid receptors in the medial preoptic area following copulation in male rats. Neuroscience 124(1):11–21
Bohn LM et al (2000) Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408(6813):720–723
Kim JA et al (2008) Morphine-induced receptor endocytosis in a novel knockin mouse reduces tolerance and dependence. Curr Biol 18(2):129–135
Rasmussen SG et al (2007) Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450(7168):383–387
Cherezov V et al (2007) High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318(5854):1258–1265
Acknowledgements
Many investigators have made major contributions to this field; I regret that only a limited subset of important papers could be cited in the present review. I am personally indebted to my mentors, colleagues, and trainees, whose intelligence and energy have driven the field forward and made working in it highly enjoyable. I gratefully acknowledge the National Institutes of Health, and particularly the National Institute on Drug Abuse, for critical financial support.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
von Zastrow, M. (2011). Opioid Receptor Trafficking. In: Pasternak, G. (eds) The Opiate Receptors. The Receptors. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-993-2_14
Download citation
DOI: https://doi.org/10.1007/978-1-60761-993-2_14
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-992-5
Online ISBN: 978-1-60761-993-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)